Ensuring care has the patient at the centre is a key aim for the NHS and something we’re particularly interested in at Anthony Nolan. Our post-transplant care pathway sets out one approach to ensuring the breadth of patients’ needs are covered after a stem cell transplant. Anthony Nolan worked with the Kings Fund to host…
The journey of a cell for research
For over 45 years Anthony Nolan has recruited potential stem cell donors to their register – people who are willing to donate their cells to someone in need of a lifesaving stem cell transplant. As this work continues, in parallel we apply our vast experience and dedicated team of experts to help develop new cell-based…
How research is improving our understanding of COVID-19 and its impact on blood cancer patients
Against daily news articles on COVID-19’s impact and possible new treatments or vaccines, it can be very hard to get a clear picture of the research landscape around the virus. Here Anthony Nolan’s Dr Jonathan Kay summarises the medical research underway to improve our understanding of COVID-19 and examines how it affects patients with blood cancer. Jonathan also talks about IMPACT’s COVID-19 clinical trial for stem cell transplant patients which is part funded by Anthony…
Transplant Workforce: It Takes a Community to Help Save Lives
Our ambition at Anthony Nolan is that every patient receives the care and support they need before, during and after a stem cell transplant, for as long as necessary and no matter where they live. Through over 45 years of supporting patients and their families, we know without the whole community of transplant staff, there is…
What makes great customer service in the world of Cell and Gene Therapies?
Thomas Painter, the Business Support Coordinator in the Anthony Nolan Cell & Gene Therapies Service, looks at how great customer service can make all the difference, and how we’re applying these learnings to deliver the best service for our customers and their patients. At Anthony Nolan, providing great customer service to our collaborators is vital…
Are cells the new pills for patients?
With new breakthroughs in cell therapies, Dr Diana Hernandez, Senior Research Scientist and Immunotherapy Group Leader at Anthony Nolan, explains the science behind these treatments, and how Anthony Nolan’s Cell & Gene Therapy Service is looking to support them. Having worked in the stem cell field for many years, it is truly exciting to see…